Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_1
1
14%
Ph phase_4
3
43%
Ph phase_3
1
14%
Ph phase_2
1
14%
Ph not_applicable
1
14%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
3(42.9%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(5)
Terminated(2)

Detailed Status

Completed5
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (14.3%)
Phase 21 (14.3%)
Phase 31 (14.3%)
Phase 43 (42.9%)
N/A1 (14.3%)

Trials by Status

terminated114%
completed571%
withdrawn114%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_2

Thyroid Hormone Supplementation in Patients With Septic Shock

NCT05270798
withdrawnnot_applicable

Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers

NCT01360177
completedphase_4

Thyroid Medication and Antidepressants for Treating Major Depression

NCT00208702
terminatedphase_4

Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression

NCT00296686
completedphase_1

Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery

NCT00289367
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05270798Phase 2

Thyroid Hormone Supplementation in Patients With Septic Shock

Completed
NCT01360177Not Applicable

Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers

Withdrawn
NCT00208702Phase 4

Thyroid Medication and Antidepressants for Treating Major Depression

Completed
NCT00296686Phase 4

Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression

Terminated
NCT00289367Phase 1

Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery

Completed
NCT00531713Phase 4

Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism

Completed
NCT00158990Phase 3

Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7